Design, synthesis and biological evaluation of novel thiosemicarbazones as cruzipain inhibitors.
Chagas disease
Cruzipain inhibitors
Drug design
QSAR
Thiosemicarbazones
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
05 Jun 2023
05 Jun 2023
Historique:
received:
30
01
2023
revised:
23
03
2023
accepted:
03
04
2023
medline:
8
5
2023
pubmed:
14
4
2023
entrez:
13
4
2023
Statut:
ppublish
Résumé
Based on the activity of 23 TSCs on CZ taken from the literature, we have developed a QSAR model for predicting the activity of TSCs. New TSCs were designed and then tested against CZP, resulting in inhibitors with IC
Identifiants
pubmed: 37054562
pii: S0223-5234(23)00311-2
doi: 10.1016/j.ejmech.2023.115345
pii:
doi:
Substances chimiques
Thiosemicarbazones
0
cruzipain
EC 3.4.22.51
Cysteine Endopeptidases
EC 3.4.22.-
Protozoan Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
115345Informations de copyright
Copyright © 2023 Elsevier Masson SAS. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.